Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics / eingereicht von Richard L. Kraus

eng: I could provide evidence that the pore region of voltage gated calcium channels emerge as structures not only important for cation permeation through the channel but also plays an important role for (1) pharmacology and (2) pathophysiology. (1) Synthesizing a novel photoreactive diltiazem- der...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:1998
Year of Publication:1998
Language:English
Subjects:
Physical Description:III, 63 Bl.; Ill., graph. Darst.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 990003080350504498
ctrlnum AC01066979
(AT-OBV)AC01066979
(Aleph)002229246ACC01
(DE-599)OBVAC01066979
(EXLNZ-43ACC_NETWORK)990022292460203331
collection bib_alma
institution YWOAW
building MAG1-3
record_format marc
spelling Kraus, Richard L. aut
Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics eingereicht von Richard L. Kraus
1998
III, 63 Bl. Ill., graph. Darst.
Innsbruck, Univ., Diss., 1998
eng: I could provide evidence that the pore region of voltage gated calcium channels emerge as structures not only important for cation permeation through the channel but also plays an important role for (1) pharmacology and (2) pathophysiology. (1) Synthesizing a novel photoreactive diltiazem- derivative, ["3H]benziazem, I could identify the BTZ binding domain within the #alpha#1 subunit of partially purified L-type calcium channels by antibody mapping and demonstrate that the binding sites for all three major chemical classes of calcium antagonists (dihydropyridines DHPs; phenylalkylamines, PAAs and BTZs) are located in close proximity within the pore-forming region of the #alpha#1 subunit. I further investigated single amino acid residues involved in high affinity BTZ binding in the transmembrane segment IIIS6 of the channel pore. Using alanine scanning mutagenesis 19 residues of segment IIIS6 were mutated to alanine. Mutant #alpha#1 subunits were coexpressed, in X. laevis oocytes and drug sensitivity to 100 #mu#M (+)-cis diltiazem, was assayed using the two- electrode voltage-clamp technique. Some amino acids are involved in BTZ as well as PAA- binding suggesting overlapping binding sites. Results of drug binding studies to partially purified calcium channels could not consistently be interpreted according to a former postulated allosteric model. Therefore we suggest allosteric and additional steric interactions to play an important role between channel bound drug molecules. (2) Mutations inducing amino acid substitutions within the calcium channel pore lead to neuronal disorders. We have introduced four single familial hemiplegic migraine (FBM) mutations reported for the human #alpha#1A subunit into the conserved rabbit isoform and investigated possible changes in channel function. Mutant and wild type rabbit #alpha#1A were coexpressed in X. laevis oocytes and calcium channel currents were analyzed. We could show that mutations associated with FHM affect kinetics of neuronal N-type calcium channel involved in neurotransmitter release.
Calciumkanal s (DE-588)4205050-9
Arzneimittelwechselwirkung s (DE-588)4003147-0
AT-OBV ONB
YWOAW MAG1-3 28472-C.Stip. 2222107570004498
language English
format Thesis
Book
author Kraus, Richard L.
spellingShingle Kraus, Richard L.
Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics
Calciumkanal (DE-588)4205050-9
Arzneimittelwechselwirkung (DE-588)4003147-0
author_facet Kraus, Richard L.
author_variant r l k rl rlk
author_role VerfasserIn
author_sort Kraus, Richard L.
title Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics
title_full Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics eingereicht von Richard L. Kraus
title_fullStr Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics eingereicht von Richard L. Kraus
title_full_unstemmed Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics eingereicht von Richard L. Kraus
title_auth Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics
title_new Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics
title_sort role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics
publishDate 1998
physical III, 63 Bl. Ill., graph. Darst.
callnumber-raw 28472-C.Stip.
callnumber-search 28472-C.Stip.
topic Calciumkanal (DE-588)4205050-9
Arzneimittelwechselwirkung (DE-588)4003147-0
topic_facet Calciumkanal
Arzneimittelwechselwirkung
illustrated Illustrated
work_keys_str_mv AT krausrichardl roleoftheporeregioninvoltagedependentcalciumchannelsfordruginteractionandchannelkinetics
status_str n
ids_txt_mv (AT-OBV)AC01066979
AC01066979
(Aleph)002229246ACC01
(DE-599)OBVAC01066979
(EXLNZ-43ACC_NETWORK)990022292460203331
hol852bOwn_txt_mv YWOAW
hol852hSignatur_txt_mv 28472-C.Stip.
hol852cSonderstandort_txt_mv MAG1-3
itmData_txt_mv 2001-12-17 01:00:00 Europe/Vienna
barcode_str_mv +YW2290570X
callnumbers_txt_mv 28472-C.Stip.
inventoryNumbers_str_mv OAW-10884
materialTypes_str_mv BOOK
permanentLibraries_str_mv YWOAW
permanentLocations_str_mv MAG1-3
inventoryDates_str_mv 20080625
createdDates_str_mv 2001-12-17 01:00:00 Europe/Vienna
holdingIds_str_mv 2222107570004498
is_hierarchy_id AC01066979
is_hierarchy_title Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics
_version_ 1793779686748192768
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02984nam#a2200301zc#4500</leader><controlfield tag="001">990003080350504498</controlfield><controlfield tag="005">20231120135753.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">980903|1998####|||######m####|||#|#eng#c</controlfield><controlfield tag="009">AC01066979</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(AT-OBV)AC01066979</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">AC01066979</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Aleph)002229246ACC01</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)OBVAC01066979</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLNZ-43ACC_NETWORK)990022292460203331</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">UBI</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="c">XA-AT</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kraus, Richard L.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Role of the pore region in voltage dependent calcium channels for drug interaction and channel kinetics</subfield><subfield code="c">eingereicht von Richard L. Kraus</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">III, 63 Bl.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Innsbruck, Univ., Diss., 1998</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">eng: I could provide evidence that the pore region of voltage gated calcium channels emerge as structures not only important for cation permeation through the channel but also plays an important role for (1) pharmacology and (2) pathophysiology. (1) Synthesizing a novel photoreactive diltiazem- derivative, ["3H]benziazem, I could identify the BTZ binding domain within the #alpha#1 subunit of partially purified L-type calcium channels by antibody mapping and demonstrate that the binding sites for all three major chemical classes of calcium antagonists (dihydropyridines DHPs; phenylalkylamines, PAAs and BTZs) are located in close proximity within the pore-forming region of the #alpha#1 subunit. I further investigated single amino acid residues involved in high affinity BTZ binding in the transmembrane segment IIIS6 of the channel pore. Using alanine scanning mutagenesis 19 residues of segment IIIS6 were mutated to alanine. Mutant #alpha#1 subunits were coexpressed, in X. laevis oocytes and drug sensitivity to 100 #mu#M (+)-cis diltiazem, was assayed using the two- electrode voltage-clamp technique. Some amino acids are involved in BTZ as well as PAA- binding suggesting overlapping binding sites. Results of drug binding studies to partially purified calcium channels could not consistently be interpreted according to a former postulated allosteric model. Therefore we suggest allosteric and additional steric interactions to play an important role between channel bound drug molecules. (2) Mutations inducing amino acid substitutions within the calcium channel pore lead to neuronal disorders. We have introduced four single familial hemiplegic migraine (FBM) mutations reported for the human #alpha#1A subunit into the conserved rabbit isoform and investigated possible changes in channel function. Mutant and wild type rabbit #alpha#1A were coexpressed in X. laevis oocytes and calcium channel currents were analyzed. We could show that mutations associated with FHM affect kinetics of neuronal N-type calcium channel involved in neurotransmitter release. </subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Calciumkanal</subfield><subfield code="D">s</subfield><subfield code="0">(DE-588)4205050-9</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="D">s</subfield><subfield code="0">(DE-588)4003147-0</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">AT-OBV</subfield><subfield code="5">ONB</subfield></datafield><datafield tag="970" ind1="2" ind2=" "><subfield code="d">HS-DISS</subfield></datafield><datafield tag="974" ind1="0" ind2="u"><subfield code="V">903</subfield><subfield code="a">21</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-17 13:30:06 Europe/Vienna</subfield><subfield code="d">20</subfield><subfield code="f">System</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-12-24 09:51:38 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="HOL" ind1="8" ind2=" "><subfield code="b">YWOAW</subfield><subfield code="h"> 28472-C.Stip. </subfield><subfield code="c">MAG1-3</subfield><subfield code="8">2222107570004498</subfield></datafield><datafield tag="852" ind1="8" ind2=" "><subfield code="b">YWOAW</subfield><subfield code="c">MAG1-3</subfield><subfield code="h"> 28472-C.Stip. </subfield><subfield code="8">2222107570004498</subfield></datafield><datafield tag="ITM" ind1=" " ind2=" "><subfield code="9">2222107570004498</subfield><subfield code="e">1</subfield><subfield code="m">BOOK</subfield><subfield code="b">+YW2290570X</subfield><subfield code="i">OAW-10884</subfield><subfield code="2">MAG1-3</subfield><subfield code="o">20080625</subfield><subfield code="8">2322107560004498</subfield><subfield code="f">02</subfield><subfield code="p">2001-12-17 01:00:00 Europe/Vienna</subfield><subfield code="h">28472-C.Stip.</subfield><subfield code="1">YWOAW</subfield><subfield code="q">2022-06-09 11:50:14 Europe/Vienna</subfield></datafield></record></collection>